Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015 % and Timolol 0.5 % in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies
Crossref DOI link: https://doi.org/10.1007/s40262-015-0331-x
Published Online: 2015-09-21
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaarniranta, Kai
Ikäheimo, Kirsi
Mannermaa, Eliisa
Ropo, Auli
Funding for this research was provided by:
Santen Oy
Text and Data Mining valid from 2015-09-21